Infections more than vaccines are inducers of autoimmune diseases

Israel Medical Association Journal

Volumn 12, Issue 10, 2010, Pages 635-637

  Toubi, Elias ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; HEPATITIS B VACCINE; INFLUENZA VACCINE;

AUTOIMMUNE DISEASE; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG ERUPTION; DRUG FEVER; EDITORIAL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HEPATITIS B; HUMAN; HUMAN PARVOVIRUS B19; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE EDEMA; INJECTION SITE HYPERSENSITIVITY; MOLECULAR MIMICRY; NONHUMAN; RISK FACTOR; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASODILATATION; VIRUS INFECTION;

AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; HUMANS; RISK FACTORS; VACCINES; VIRUS DISEASES;

EID: 78449242535     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. Sfriso P, Ghirardello A, Botsios C, et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010; 87: 385-95.
2. Stratta P, Canavese C, Ciccone G, et al. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron 1999; 82: 145-54.
3. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001; 44: 1122-6.
4. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Hareley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11: 85-9.
5. Ramos-Casals M, Cuadrado MJ, Alba P, et al. Acute viral infections in patients with systemic erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 2008; 87: 311-18.
6. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr Virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083-8.
7. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006; 63: 839-44.
8. Pender MP. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev 2009; 8: 563-8.
9. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 362: 1659-66.
10. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccination and autoimmunity. Nat Rev Rheumatol 2009; 5: 648-52.
11. Vial T, Descotes J. Autoimmune diseases and vaccination. Eur J Dermatol 2004; 14: 86-90.
12. Chen RT, Pless R, Destrefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001; 16: 309-18.
13. Agmon-Levin N, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies - the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev 2008; 8: 52-5.
14. Haber P, DeStefano F, Angulo FJ, et al. Guillain- Barre syndrome following influenza vaccination. JAMA 2004; 292: 2478-81.
15. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Sum 2003; 52: 1-24.
16. Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain- Barre syndrome after vaccination in the United States: a report from CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 2007; 25: 5253-5.
17. Tourbah A, Gout O, Liblau R, et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999; 53: 396-401.
18. Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk for multiple sclerosis. N Engl J Med 2001; 344: 327-32.
19. Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 2008; 8: 134-8.
20. Ryan AM, Bermingham N, Harrington HJ, Keohane C. Atypical presentation of macrophagic myofasciitis 10 years post vaccination. Neuromuscul Disord 2006; 16: 867-9.
21. Meyer A, Rotman-Pikielny P, Natour A, Levy Y. Antiphospholipid syndrome following a diphtheria-tetanus vaccination: coincidence versus causality. IMAJ Isr Med Assoc J 2010; 12: 638-9.
22. Holvast B, Huckriede A, Kallenberg CG, BiJl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007; 6: 300-5.
23. Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 2007; 6: 312-14.
24. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008; 8: 124-8.